XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Retained Earnings
Beginning balance at May. 01, 2021 $ 918.0 $ 19.8 $ 157.6 $ 6.1 $ (11.5) $ 746.0
Beginning balance (in shares) at May. 01, 2021   39,644,913        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, net of tax withholding (0.3) $ 0.1 (0.1)     (0.3)
Issuance of restricted stock, net of tax withholding (in shares)   44,245        
Exercise of stock options 0.5   0.5      
Exercise of Stock Options (in shares)   13,000        
Purchases of common stock $ (42.4) $ (0.5)       (41.9)
Purchases of common stock (in shares) (965,029) (965,029)        
Stock-based compensation expense $ 5.8   5.8      
Other comprehensive income (loss) (8.1)     (8.1)    
Net income 56.6         56.6
Dividends on common stock (10.6)         (10.6)
Ending balance at Oct. 30, 2021 919.5 $ 19.4 163.8 (2.0) (11.5) 749.8
Ending balance (in shares) at Oct. 30, 2021   38,737,129        
Beginning balance at Jul. 31, 2021 934.3 $ 19.8 161.2 2.9 (11.5) 761.9
Beginning balance (in shares) at Jul. 31, 2021   39,544,645        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Purchases of common stock $ (34.8) $ (0.4)       (34.4)
Purchases of common stock (in shares) (807,516) (807,516)        
Stock-based compensation expense $ 2.6   2.6      
Other comprehensive income (loss) (4.9)     (4.9)    
Net income 27.5         27.5
Dividends on common stock (5.2)         (5.2)
Ending balance at Oct. 30, 2021 919.5 $ 19.4 163.8 (2.0) (11.5) 749.8
Ending balance (in shares) at Oct. 30, 2021   38,737,129        
Beginning balance at Apr. 30, 2022 913.8 $ 19.2 169.0 (26.8) (11.5) 763.9
Beginning balance (in shares) at Apr. 30, 2022   38,276,968        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, net of tax withholding (0.4)         (0.4)
Issuance of restricted stock, net of tax withholding (in shares)   54,479        
Purchases of common stock $ (31.6) $ (0.5)       (31.1)
Purchases of common stock (in shares) (825,814) (825,814)        
Stock-based compensation expense $ 5.7   5.7      
Other comprehensive income (loss) (27.5)     (27.5)    
Net income 49.1         49.1
Dividends on common stock (10.3)         (10.3)
Ending balance at Oct. 29, 2022 898.8 $ 18.7 174.7 (54.3) (11.5) 771.2
Ending balance (in shares) at Oct. 29, 2022   37,505,633        
Beginning balance at Jul. 30, 2022 911.4 $ 19.0 172.0 (36.2) (11.5) 768.1
Beginning balance (in shares) at Jul. 30, 2022   38,001,714        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, net of tax withholding (in shares)   12,098        
Purchases of common stock $ (19.7) $ (0.3)       (19.4)
Purchases of common stock (in shares) (508,179) (508,179)        
Stock-based compensation expense $ 2.7   2.7      
Other comprehensive income (loss) (18.1)     (18.1)    
Net income 27.6         27.6
Dividends on common stock (5.1)         (5.1)
Ending balance at Oct. 29, 2022 $ 898.8 $ 18.7 $ 174.7 $ (54.3) $ (11.5) $ 771.2
Ending balance (in shares) at Oct. 29, 2022   37,505,633